On Wednesday the 24th of January 2024, the IPPS will host a launch event to explore the findings of the third 100 Days Mission annual implementation report. This report is a ‘pulse check’ for how close the world is to achieving the 100 Days Mission, which outlines the progress made in 2023, the barriers to action, and opportunities to overcome them, including leveraging investments that are complementary to tackling other global health issues.
This event will:
1. Publicly launch the third implementation report for the 100 Days Mission, sharing its key findings and areas for action in 2024;
2. Explore and explain how the 100 Days Mission can be implemented at the global, regional and national level;
3. Convene partners from all sectors for practical discussions on implementing proposed 2024 priorities
To receive the Zoom link, please register here.
Event Programme
09.00 – 09.15 | Welcome & Opening Remarks
– Prof Rino Rappuoli, Scientific Director of the Biotecnopolo di Siena Foundation and head of MAD Lab Toscana Life Sciences, Italy
– Dr Sergio Iavicoli, Director General of Communication and European and International Relations of the Ministry of Health, Italy
– Dr Jeremy Farrar, Chief Scientist, WHO
09.15 – 10.30 | Panel 1: 100DM 3rd Implementation Report Findings: What’s New & What’s Next?
– Dr Victor Dzau (Moderator), President of the National Academy of Medicine & 100 Days Mission Science and Technology Expert Group Co-chair
– Prof Teresa Lambe OBE, Calleva Head of Vaccine Immunology & Professor of Vaccinology & Immunology at University of Oxford
– Dr Mariângela Simão, Director-president of the Instituto Todos pela Saúde
– Dr Ruxandra Draghia-Akli, Former Global Head, Global Public Health R&D at Johnson & Johnson
– Dr Sergio Carmona, Acting CEO and Chief Medical Officer, FIND, the global alliance for diagnostics
Description:
This session features members of the 100DM STEG, as well as key implementation partners. It sets out the main findings from the 2023 100 Days Mission Annual Report, including top line messages from the new 100 Days Mission Scorecard and the 100DM Therapeutics Roadmap. The session will also set out the 100DM priorities for 2024, including concrete actions needed to push these elements forwards.
10.45 – 11.30 | Panel 2: 100 Days Mission: In Practice
– Dr Mona Nemer (Moderator), Chief Science Advisor of Canada & 100 Days Mission Steering Group Chair
– Dr Samia Saad, Executive Director of Resource Mobilisation & Investor Relations, CEPI
– Dr Philippe Duneton, Executive Director, Unitaid
– Pushpa Vijayaraghavan, Director and Practice Lead, Healthcare & Innovation Advisory, at Sathguru Management Consultants, MPP Board Member
– Dr Marco Cavaleri, Head of Office, Health Threats and Vaccines Strategy, European Medicines Agency (EMA)
Description:
What does implementing the 100 Days Mission look like in practice? This second session will hear from key implementing partners across the DTV value chain to understand what is already being done to progress closer towards this goal. It will delve into what challenges partners are facing and where the G7, G20 and other actors can take specific actions to ensure success.
11.30 – 12.15 | Panel 3: 100 Days Mission: Implementation at the Global, Regional & National Levels
– Shingai Machingaidze (Moderator) Acting Chief Science Officer, Africa CDC & 100 Days Mission Science and Technology Expert Group Co-chair
– Prof Rino Rappuoli, Scientific Director of the Biotecnopolo di Siena Foundation and head of MAD Lab Toscana Life Sciences, Italy
– Aggrey Aluso Odhiambo, Director, Africa Region for the Pandemic Action Network (PAN) and the Executive Director of Resilience Action Network Africa (RANA)
– Dr Renu Swarup, Former Secretary of the Department of Biotechnology, Ministry of Science & Technology, Government of India
– Dr Thomas Cueni, Director General of International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Description:
The third session of this event looks at what it will take to implement the 100DM at the national, regional and global level. The panel will explore how effective cross-sectoral public-private partnerships can be facilitated; the ways in which regional governance can bridge the gap between national and global efforts; and countries’ roles in early-stage R&D and technological advancements.
12.15 – 12.30 | Summary Remarks
– Sir Patrick Vallance, Chairman of the Board of Trustees, Natural History Museum, Former UK Chief Scientific Advisor & Former 100 Days Mission Steering Group Chair
– Dr Mona Nemer, Chief Science Advisor of Canada & 100 Days Mission Steering Group Chair
Please click here for a full list of speaker biographies.